← FDA DRUG APPROVALS

FDA ANDA · ANDA202847

FLUOCINOLONE ACETONIDE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA202847
TYPE
ANDA
ORIGINAL APPROVAL
2013-08-09
LATEST ACTION
2025-09-03
ROUTE
TOPICAL
DOSAGE FORM
OIL
MARKETING STATUS
Prescription

Products

FLUOCINOLONE ACETONIDEPrescription
FLUOCINOLONE ACETONIDE 0.01% · OIL · TOPICAL

Approval history

2025-09-03Labeling · Supplement 13 · standardAP
2013-08-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →